The third dose of the coronavirus vaccine is now being given to persons age 12 or older who belong to risk groups 1 and 2. The vaccine is given without an appointment at the vaccination points.
Later on, it will also be possible to book a vaccination appointment. Appointment booking for the third dose for this group will open soon and will be announced separately.
The vaccination points and their opening hours are listed at hel.fi/vaccination.
The third dose can be given to people aged 12-17 and who belong to risk groups at the earliest six months after the second dose. People who have recovered from COVID-19 and received two doses of the vaccine do not currently need a third dose for protection.
A third dose may also be given to other people aged 12–17 if it is necessary for special reasons, such as a vaccination certificate. In this case, the third vaccine dose should be given at least six months after the second dose.
Illnesses and conditions that very highly expose to severe COVID-19 (risk group 1)
Illnesses and conditions that expose to severe COVID-19 (risk group 2)
Vaccination requires guardians’ consent
A minor may decide independently to get the coronavirus vaccine if a health care professional judges the minor able to make the decision based on age and mental developmental. The situation is assessed at the vaccination point.
If the young person is not able to make the decision on vaccination independently, the written consent of both guardians is required for the vaccination. Consent
is given with this form(Link leads to external service). If the young person received the first and/or second dose of the coronavirus vaccine in Helsinki with parental consent, the form does not need to be brought to the vaccination point again.
More information
- COVID-19 vaccinations of Helsinkians – coronavaccination-en.hel.fi
- THL, Vaccines and coronavirus – thl.fi/coronavaccine(Link leads to external service)
Photo: Virpi Velin
News was updated 10 March: The third vaccine dose can be given to people aged 12-17 and who belong to risk groups at the earliest six months after the second dose.